Gano Kyle

Gano Kyle is listed in filings as Chief Executive Officer at Neurocrine Biosciences Inc. This profile follows SEC Form 4 activity through Feb 17, 2026, including sale activity. Recent filings connect the profile to Neurocrine Biosciences Inc (NBIX). The current snapshot covers public activity from Nov 4, 2025 to Feb 17, 2026. Reported amounts are shown as $14.3M to $171.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.